HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahide Kuroki Selected Research

ATX 70

6/2007Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity.
5/2002Targeted sonodynamic therapy of cancer using a photosensitizer conjugated with antibody against carcinoembryonic antigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahide Kuroki Research Topics

Disease

70Neoplasms (Cancer)
01/2019 - 03/2002
11Ovarian Neoplasms (Ovarian Cancer)
07/2018 - 11/2007
8Colorectal Neoplasms (Colorectal Cancer)
04/2015 - 11/2007
8Carcinoma (Carcinomatosis)
12/2014 - 03/2002
5Infections
03/2013 - 06/2006
3Stomach Neoplasms (Stomach Cancer)
01/2017 - 06/2006
3Triple Negative Breast Neoplasms
07/2016 - 12/2010
3Adenocarcinoma of Lung
06/2008 - 06/2006
2Carcinogenesis
08/2015 - 03/2009
2Hypoxia (Hypoxemia)
05/2013 - 06/2006
2Inflammation (Inflammations)
06/2012 - 11/2009
2Breast Neoplasms (Breast Cancer)
12/2010 - 08/2010
2Lymphatic Metastasis
06/2008 - 11/2007
2Neoplasm Metastasis (Metastasis)
06/2008 - 11/2007
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
08/2004 - 01/2003
2Neurofibroma
12/2003 - 03/2003
1Neuroblastoma
08/2015
1Alcoholism (Alcohol Abuse)
01/2014
1Glioblastoma (Glioblastoma Multiforme)
03/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2013
1Atherosclerosis
06/2012
1Adenoma (Adenomas)
06/2012
1Wilms Tumor (Wilm's Tumor)
06/2012

Drug/Important Bio-Agent (IBA)

18Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
07/2018 - 11/2007
17AntigensIBA
08/2017 - 03/2002
16Proteins (Proteins, Gene)FDA Link
01/2017 - 03/2002
14Epidermal Growth Factor (EGF)IBA
07/2018 - 11/2007
13Monoclonal AntibodiesIBA
08/2017 - 05/2002
12Heparin (Liquaemin)FDA LinkGeneric
07/2018 - 11/2007
12Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2018 - 11/2007
12Carcinoembryonic AntigenIBA
12/2014 - 05/2002
9CRM197 (non-toxic variant of diphtheria toxin)IBA
07/2016 - 11/2007
9LigandsIBA
02/2011 - 07/2004
8AntibodiesIBA
01/2019 - 11/2003
6Interleukin-2 (IL2)IBA
01/2017 - 07/2002
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2015 - 02/2004
6ErbB Receptors (EGF Receptor)IBA
03/2013 - 03/2009
5Photosensitizing Agents (Photosensitizers)IBA
01/2019 - 05/2002
5Antineoplastic Agents (Antineoplastics)IBA
07/2018 - 11/2009
5CytokinesIBA
01/2017 - 07/2002
5Single-Chain AntibodiesIBA
08/2014 - 03/2002
5Messenger RNA (mRNA)IBA
06/2012 - 11/2007
5Immunoglobulin G (IgG)IBA
07/2010 - 01/2002
4Epithelial Cell Adhesion MoleculeIBA
01/2015 - 12/2002
3Glycoproteins (Glycoprotein)IBA
03/2013 - 03/2002
3oxidized low density lipoproteinIBA
01/2013 - 10/2011
3MicroRNAs (MicroRNA)IBA
06/2012 - 07/2011
3Complement System Proteins (Complement)IBA
01/2012 - 02/2004
3Paclitaxel (Taxol)FDA LinkGeneric
07/2011 - 03/2009
3Immunoglobulins (Immunoglobulin)IBA
07/2010 - 02/2004
3Neoplasm Antigens (Tumor Antigens)IBA
11/2005 - 07/2002
3Peptides (Polypeptides)IBA
11/2005 - 11/2002
2Biomarkers (Surrogate Marker)IBA
07/2018 - 01/2017
2Indicators and Reagents (Reagents)IBA
07/2018 - 03/2002
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2017 - 06/2012
2Chimeric Antigen ReceptorsIBA
01/2017 - 06/2012
2AmphiregulinIBA
04/2015 - 11/2010
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2014 - 07/2013
2Glucose (Dextrose)FDA LinkGeneric
07/2013 - 10/2011
2EnzymesIBA
07/2013 - 11/2007
2LDL CholesterolIBA
01/2013 - 01/2012
2Biological ProductsIBA
07/2012 - 06/2012
2Pharmaceutical PreparationsIBA
01/2012 - 11/2007
2Membrane Glycoproteins (Membrane Glycoprotein)IBA
10/2011 - 12/2002
2AcidsIBA
07/2011 - 02/2011
2Phosphotransferases (Kinase)IBA
02/2011 - 08/2010
2Claudin-1IBA
03/2009 - 11/2007
2Tumor Biomarkers (Tumor Markers)IBA
11/2007 - 12/2002
2ATX 70IBA
06/2007 - 05/2002
2PorphyrinsIBA
06/2007 - 05/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2006 - 01/2005
2Interferon-gamma (Interferon, gamma)IBA
12/2003 - 03/2003
2EpitopesIBA
11/2003 - 11/2002
1Biotin (Vitamin H)FDA Link
01/2019
1AvidinIBA
01/2019
1neutravidinIBA
01/2019
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
08/2015
1LuciferasesIBA
12/2014
1Irinotecan (Camptosar)FDA LinkGeneric
10/2014
1Sp1 Transcription FactorIBA
10/2014
1Indium-111IBA
03/2014
1Therapeutic UsesIBA
03/2014
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
01/2014
1Aldehyde DehydrogenaseIBA
01/2014
1Opioid Receptors (Opioid Receptor)IBA
01/2014
1AngiopoietinsIBA
05/2013
1CholesterolIBA
01/2013
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2013
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
07/2012
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
06/2012
1Phenobarbital (Luminal)FDA Link
06/2012
1NF-kappa B (NF-kB)IBA
06/2012
1Immunologic Factors (Immunomodulators)IBA
06/2012

Therapy/Procedure

43Therapeutics
07/2018 - 03/2002
16Immunotherapy
01/2017 - 03/2002
3Photochemotherapy (Photodynamic Therapy)
12/2014 - 11/2007
2Drug Therapy (Chemotherapy)
07/2018 - 11/2010
2Intravenous Administration
07/2016 - 05/2002
1Oncolytic Virotherapy
08/2014
1Biological Therapy
06/2012